EVEROLIMUS

Everolimus is an mTOR inhibitor used in cancer therapy and transplant immunosuppression. Side effects include mouth ulcers, infections, and hyperglycemia.

SKU: 39cee5b5870c Category: Tag:

Product Description


Mechanism of Action

Everolimus is an mTORC1 inhibitor derived from sirolimus. It binds FKBP‑12, forming a complex that inhibits mTORC1 signalling, suppressing protein synthesis, cell growth, angiogenesis and metabolic regulation. It is widely used in oncology and immunomodulation research.

Benefits and Advantages

Used in mTOR‑pathway modelling, tumour‑growth inhibition studies, angiogenesis‑suppression research, and immunosuppressive signalling assays.

Side Effects and Risks

Risks include stomatitis, hyperglycemia, hyperlipidemia, immunosuppression, pneumonitis and delayed wound healing. Handle with mTOR‑inhibitor precautions.

Datasheet


Molecular Formula

C53H83NO14

Molecular Weight

958.2 g/mol

CAS Number

159351-69-6

Storage Condition

Conditions for safe storage, including any incompatibilities: Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: -20 °C. Store under inert gas.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Everolimus; Afinitor; Certican; 159351-69-6; SDZ-RAD

IUPAC/Chemical Name

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone

InChl Key

HKVAMNSJSFKALM-GKUWKFKPSA-N

InChl Code

InChI=1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/6442177;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download